The store will not work correctly when cookies are disabled.
ID: ALA2397462
Max Phase: Preclinical
Molecular Formula: C13H9ClF3N3O
Molecular Weight: 315.68
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NCc1ccccc1C(F)(F)F)c1cnc(Cl)cn1
Standard InChI: InChI=1S/C13H9ClF3N3O/c14-11-7-18-10(6-19-11)12(21)20-5-8-3-1-2-4-9(8)13(15,16)17/h1-4,6-7H,5H2,(H,20,21)
Standard InChI Key: DKJOWMGJADPUFZ-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 315.68 | Molecular Weight (Monoisotopic): 315.0386 | AlogP: 3.08 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.45 | CX Basic pKa: | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.95 | Np Likeness Score: -1.82 |
References
1. Servusová B, Vobicková J, Paterová P, Kubíček V, Kuneš J, Doležal M, Doležal M, Zitko J.. (2013) Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides., 23 (12): [PMID:23659859] [10.1016/j.bmcl.2013.04.021] |